Skip to main content
Bentham Open Access logoLink to Bentham Open Access
. 2026 Jun 10;22:E15734056420925. doi: 10.2174/0115734056420925251127020640

Detection and Classification of Pancreatic Cancer Nodules on CT Images using U-Net and Ensemble Models

V M Manesh 1,2,*, M Subramoniam 1, S Poornapushpakala 1, Rahul Krishnan 3
PMCID: PMC13613299  PMID: 42300307

Abstract

Introduction

Pancreatic Adenocarcinoma (PDAC) is the fourth leading cause of cancer-related mortality, predominantly affecting individuals over 45 years. Conventional diagnostic imaging modalities such as CT, MRI, PET, and ultrasound remain limited in detecting early-stage disease. Advances in deep learning (DL) hold promise for enhanced segmentation and early detection of pancreatic tumors.

Methods

This study proposes an AI-based framework for the early detection of PDAC from CT images. Noise reduction was performed using a Boosted Adaptive Diffusion Filter (BADF). Tumor segmentation was achieved with a modified U-Net model, optimized using the Adam optimizer. Classification was conducted through an ensemble learning approach. The framework was validated on publicly available CT datasets, with performance assessed using standard evaluation metrics.

Results

The proposed model achieved 98.7% accuracy, 98.7% precision, 97.92% specificity, and 99.63% AUC in distinguishing pancreatic cancers, including tumors smaller than 2 cm. These results demonstrate superior performance compared to existing DL-based approaches.

Discussion

Integration of BADF preprocessing, U-Net-based segmentation, and ensemble classification enhanced model robustness and detection accuracy. The framework addresses challenges in small tumor detection, a critical factor in improving clinical outcomes.

Conclusion

The proposed method demonstrates significant potential for early PDAC detection using CT images. By combining advanced preprocessing, segmentation, and ensemble learning, the framework enhances diagnostic accuracy and reliability, supporting clinical decision-making and contributing to improved patient care.

Keywords: Deep learning, Image segmentation, Regions of interest, Pre-processing, Noise reduction, Data augmentation, Hyperparameter tuning

1. INTRODUCTION

According to projections by the American Cancer Society, approximately 66,440 individuals (34,530 men and 31,910 women) in the US will receive a pancreatic cancer diagnosis in 2024. An estimated 51,750 individuals, 27,270 men, and 24,480 women, will pass away from pancreatic cancer. The Pancreas is ranked 18th in mortality and 24th in new cases (1.03%) in India [1]. Despite being a rare disease, pancreatic cancer (PC) is one of the world's top causes of death, and the epidemiology of PC is poorly understood.

PET has long been acknowledged as a very sensitive and precise tool to diagnose pancreatic cancer. The accuracy ranges from 64% to 91%, whereas the stated sensitivity (SE) spans from 78% to 95%. Results are improved to 85%-97% and 85%-95% by the combination of PET [2]. Tumor markers are proteins synthesized by pancreatic cancer cells, which can be identified through blood tests. CA19-9 is a tumor marker test employed in the diagnosis of pancreatic cancer. This test is routinely conducted by physicians before and following therapy to assess the cancer's response. In the context of PDAC, Carcinoembryonic Antigen (CEA) ranks as the second most frequently utilized biomarker. Research indicates that the combination of serum markers such as CA 19.9 and CA 125 may enhance the diagnostic accuracy of pancreatic cancer by differentiating patients from healthy controls [3, 4].

However, existing diagnostic tools often fail to detect cancer at an early stage, particularly when tumors are small or non-nodular. Biomarkers are promising tools for prioritizing high-risk individuals for screening, but they lack spatial localization and morphological detail. Hence, integration with imaging and computational methods is essential.

Computer-aided diagnosis/detection (CAD) is an established area of research that is rapidly advancing. There are numerous ways to raise the sensitivity and prediction accuracy of imaging techniques. These include using contrast agents to enhance sensitivity and resolution and using image processing software to increase diagnostic precision [5]. The field of image-driven pancreatic cancer diagnosis has changed dramatically in recent years with the advent of artificial intelligence and deep learning, leading to a significant increase in prediction accuracy. The primary driving forces behind AI-based cancer detection are deep learning (DL) and machine learning (ML) methodologies. Large datasets are analyzed via ML, which employs computational techniques to find predictive patterns.

Most existing techniques do not fulfill all clinical needs. Many computerized pancreatic cancer detection systems have been proposed, a majority focuses on detecting and classifying tumors. However, there is often insufficient attention given to the optimal selection of features and to the detection of small or irregular lesions, which are crucial for early diagnosis. Small lesion detection is challenging, and due to their subtle appearance in CT images, they are often overlooked by both traditional algorithms and radiologists. This highlights a significant research gap in automated, high-sensitivity approaches that can reliably identify pancreatic lesions, especially at an early stage.

A complex and difficult task for computer vision research-ers is the automated identification of pancreatic nodules in CT images. This is due to noise, overlapping anatomical structures, and the low contrast between the pancreas and its surroundings, all of which complicate lesion detection and segmentation [6]. Therefore, efficient automatic detection is required to aid radiologists and reduce human error.

Currently, an advanced version of deep learning is used to predict cancer at its early stage to develop its efficacy. This research introduces a new model based on the U-Net architecture and a modified ensemble classifier that combines models like FCN, Unet, and Densenet for accurately detecting pancreatic cancer using image processing and deep learning techniques. Using multiple models together reduces errors that can happen when using just one model. It also compares the performance of the proposed model with FCN and Densenet models to evaluate effectiveness.

Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest malignancies, often diagnosed at an advanced stage due to the lack of early symptoms and the difficulty of identifying small tumors in medical imaging. Traditional imaging-based diagnostic methods, such as CT, MRI, PET, and ultrasound, suffer from limited sensitivity in detecting early or non-nodular tumors. While several deep learning (DL) techniques have been introduced in recent literature for tumor detection, many models struggle with low contrast regions, noise artifacts, and inconsistent tumor morphology. In particular, this work focuses on detecting small pancreatic cancers, including those that do not appear as discrete nodules, which are often missed in conventional methods. The use of BADF preprocessing enhances subtle features and boundary clarity, allowing the model to capture minute changes associated with early-stage or non-nodular tumors. This provides a substantial advantage over traditional models that rely primarily on nodular appearances. Hence, this study aims to develop an accurate and efficient deep learning framework that enhances early detection of pancreatic cancer using CT images by integrating a noise-filtering technique (BADF), a modified U-Net for segmentation, and an ensemble classifier combining DenseNet, FCN, and U-Net. The model's high accuracy, especially in identifying tumors smaller than 2 cm, underscores its clinical potential. This research aims to develop a perfect CAD system for the classification of benign and malignant pancreatic tumors in CT images using image processing techniques and machine learning algorithms. Hence, in this work, a novel automatic CAD is designed and developed to help the radiologist detect possible abnormal lesions accurately. Some of the existing model of CAD for the pancreatic image classification process is described in Section 2.

2. RELATED WORKS

In recent years, Computer-Aided Detection (CAD) frameworks have been developed to assist radiologists in analyzing screening CT scan images. However, the benefits of current CAD technologies have been inconsistent, and therefore, they need further improvement to be considered truly valuable. Since 2020, deep learning and machine learning have been a significant achievement in image recognition, arriving at human-level execution.

McGuigan et al. [7], provided an overall review of pancreatic cancer, including clinical diagnosis, epidemiology, treatment options, and patient prognosis. They stressed delays in diagnoses secondary to the lack of specificity of symptoms and the pivotal role of imaging and histological confirmation in clinical practice. Zhang et al. [8] summarized a review on pancreatic cancer epidemiology, detection, and management modalities, emphasizing challenges in early detection and the need for imaging techniques such as CT and MRI. In revving up testing, the paper stressed weaknesses in current detection plans that could fail to catch cases in time. Ilic M and Ilic I [9] studied the epidemiological implications of pancreatic cancer, reviewing the dramatic trend in incidence and mortality as well as the impact of specific risk factors on different populations. Their findings reinforced the aggressive nature of the disease and the need for improved detection pathways. Vasen et al. [10] performed long-term prospective follow-up studies in high-risk individuals across three European expert centers. With their imaging and biomarker-driven surveillance method, they proved that rigorous monitoring is able to detect the disease in earlier stages. Hu et al. [11] reviewed trends in epidemiology and risk factors for pancreatic cancer. The paper described demographic differences, environmental risk determinants, and exciting temporal incidence updates, providing a better insight into the burden of the disease along with its determinants. Neoptolemos et al. [12] presented a comprehensive summary of therapeutic advances in pancreatic cancer, including chemotherapy, radiotherapy, and targeted therapy. They reported on ongoing issues in treatment and further described new therapeutic prospects that have the potential to support advances in diagnosis. Zhang et al. [13] identified the major diagnostic problems in pancreatic cancer, including those of the imaging technique, overlapping of the anatomic structures, and detection of the early lesions. They emphasized the need to develop imaging further for a more accurate diagnosis. Gilliland et al. [14] investigated nutritional and metabolic derangements associated with pancreatic cancer and pancreatic resections. Their experience gave us insight into the systemic impacts of the disease that can make clinical treatment and patient recovery very complex. Singhi et al. [15] explored the genetic architecture of pancreatic ductal adenocarcinoma (PDAC) through real-time targeted genome profiling. They found a spectrum of genetic mutations with potential for targeted therapies and biomarkers. The risk factors, diagnostic methods, and therapy treatment for pancreatic carcinoma have been reviewed by Zhao and Liu [16]. They emphasized the importance of accurate imaging and early diagnosis for better treatment results and patient survival. Versteijne et al. [17] shared long-term results from the Dutch PREOPANC randomized trial. This trial compared neoadjuvant chemoradiotherapy with upfront surgery for patients with resectable and borderline resectable pancreatic cancer. Their findings showed how preoperative treatment strategies affect survival outcomes.

These studies offer valuable insights into the epidemiology, diagnosis, treatment, and management of pancreatic cancer. However, they also reveal ongoing challenges, especially in the detection of small or early-stage tumors and in the precision of imaging assessments. These issues emphasize the need for better computational methods and image analysis techniques that can aid in earlier diagnosis and improve clinical decision-making. Addressing this gap, our research proposes a specialized deep learning-based system for early pancreatic cancer detection, focusing on small or non-nodular tumors. We introduce an ensemble deep learning model that integrates Fully Convolutional Networks (FCN), U-Net, and DenseNet architectures. This combination leverages the strengths of each model while mitigating individual weaknesses through model fusion. The ensemble classifier, supported by a denoising technique (BADF) and a modified U-Net for segmentation, significantly improves detection accuracy, particularly for tumors<2 cm. Compared to single-model approaches, the proposed system enhances prediction performance, reduces false positives, and supports radiologists through an effective Computer-Aided Diagnosis (CAD) system for classifying benign and malignant pancreatic lesions in CT images.

2.1. Research Contribution

  • To propose a new model for detecting pancreatic cancer, accurately using image processing and deep learning techniques.

  • To identify pancreatic cancer at an early stage and thereby increase the survival rate.

  • To solve the curse of dimensionality problem and select the finest features from the extracted features.

  • To develop an efficient framework based on ensemble classification that provides an optimal solution for detecting pancreatic cancer.

  • To enhance the operations in each phase to improve the overall performance.

  • To compare the various existing systems and reach the maximum accuracy in the proposed system.

  • To assist the physicians in faster and accurate detection of cancer.

The rest of this article is structured in the following way. The key deep learning techniques used for medical image analysis and defined in the survey are presented in Section 2. Section 3 describes the contributions to the role of grade recognition from optimized deep learning in medical image analysis: improvement, detection, segmentation, and classification. In various areas of use, Section 4 analyses the findings obtained and the open challenges. Finally, Section 5 concludes the paper.

3. METHODOLOGY

The CAD framework receives the images as input. During the overall processing stage, the obtained image is digitized and examined for the prominent visibility of anatomical structures. Pre-processing techniques and analysis are explained in detail because overall processing mostly focuses on the acquisition method and the physician's decision on the regular procedures that are followed.

Pre-processing aims to preserve tumor region pixels so that the features extracted accurately describe the characteristics of tumor tissues. The methods of feature extraction employed to get descriptive features determine how much analysis is done. At this point, the effectiveness of the features in the measurement of tissue characteristics is determined by the clinical expertise and knowledge of the doctor. The machine learning methods are empowered with features of images of different age groups and used as a reference database. Before building a database, the sort of pathology involved is discussed with doctors throughout the training phase. After the CAD system is implemented, test photos of an unidentified category are used to evaluate the discriminating capabilities. In addition, information regarding the category is sent to the doctors to aid in diagnosis. It is assumed that such a CAD method can also be used to meet the different possibilities. The overall architecture diagram of the proposed framework is presented in Fig. (1).

Fig. (1).

Fig. (1)

Proposed block diagram.

This study focuses on analyzing pancreatic CT images from the Cancer Imaging Archive (TCIA) dataset. The images undergo pre-processing, including resizing for uniform dimensions to ensure algorithm compatibility and normalizing pixel intensity values to a consistent range (e.g., [0,1] or [-1,1]) to enable stable training. Additionally, denoising is performed using the Boosted Adaptive Diffusion Filter (BADF). Data augmentation techniques such as rotation, flipping, cropping, and random brightness adjustment are applied to improve model robustness and generalization. The pancreas region is extracted, and segmentation is carried out using a modified U-Net architecture. The segmentation performance is evaluated by comparing the predicted pixel labels from the U-Net with ground-truth labels created for 80 validation images. Feature selection is conducted using Principal Component Analysis (PCA), and classification is performed using an ensemble model that combines DenseNet, FCN, and U-Net classifiers. Parameter optimization is achieved using Adam and SGD with momentum. The final model is assessed using standard evaluation metrics, including Accuracy, Precision, Recall, F1-Score, and AUC.

3.1. Data Set

This work utilizes pancreatic CT images obtained from The Cancer Imaging Archive (TCIA) dataset (https://www.cancerimagingarchive.net/access-data/). Each image has a resolution of 512×512 pixels and a slice thickness ranging from 1.5 mm to 2.5 mm. The study focuses on patients above 45 years of age, and a total of 82 abdominal CT scans were collected from the National Institutes of Health [18]. Figure 2 illustrates a sample from the dataset.

Fig. (2).

Fig. (2)

Samples of the TCIA dataset.

3.2. Image Preprocessing

Pre-processing can be termed as the process of removing noise from the image. It is done to remove noisy values and fill missing values to select the optimal features for predicting whether pancreatic cancer is present or not in individuals. If data contains any missing values, the median/mean of the non-missing values in a column is calculated, and then the missing value is replaced within each column [19].

3.2.1. Image Resizing

The image of the eye undergoes pre-processing steps before it goes through segmentation. It is necessary to resize the images to ensure that they are all the same size to be algorithm-compatible. Ultimately, unwanted pixel information will disappear from the image. All the images have been resized for further processing into the same size with w = 183 and L = 275. s. Fig. (3a) shows the original image, and Fig. (3b) shows the resized image.

Fig. (3).

Fig. (3)

(a) Original image; (b) Resized image.

3.2.2. Normalization

Normalize the image intensity values to a consistent range, such as [0,1] or [-1,1], to stabilize the training process. This can be done by subtracting the mean and dividing by the standard deviation of the image pixels.

3.2.3. Data Augmentation

Another strategy to lessen overfitting in models is data augmentation, which involves increasing the quantity of training data while retaining the information found solely in the training data. The area of data augmentation is not new; in fact, several approaches to data augmentation have been used to solve particular issues. The primary augmentation mechanisms employed in this work are applied, including rotation, flipping, cropping, and random brightness augmentation.

  • Cropping: When using the cropping approach, an image with varying height and breadth can be effectively cropped by cutting a central piece of the image. Additionally, random crops can be employed to create strikingly similar translations.

  • Noise Injection: A random value matrix derived from the Gaussian distribution consists primarily of noise injection. Adding picture noise can enhance the performance of convolutional neural networks (CNNs). Discrepancies in training outcomes related to position can be effectively resolved through geometric modifications. Isolating the training data distribution from test data can mitigate various potential sources of bias. Geometric adjustments effectively address positional distortions, ensuring that each face is perfectly focused within the frame. Geometric modifications are beneficial not only for their effectiveness in counteracting positional biases but also for their ease of implementation.

  • Rotation: Increase (modify = 30, 60, 90, 120, 150, 180, 210, 240, 270, 300, 330°) the multi-angle rotation data, and then rotate the original image and the 11-angle rotation images both vertically and horizontally. The procedure not only generates more samples but also prevents overfitting.

  • Flipping: An image flip refers to the reversal of rows or columns of pixels, which can occur either horizontally or vertically. Vertical flips are presumed to capture a distinctive characteristic of medical images, specifically invariance under vertical reflection. Vertical flips often fail to represent natural photographs; therefore, horizontal flips are predominantly used for such images. A vertically flipped mass would still yield a realistic mass outcome.

  • Brightness augmentation: The contrast that some CT images include, which can occasionally be diminished in some images, is improved using the BADF technique

Its main goal is to eliminate disturbance by shielding small details in the image [20]. This BADF enhances the existing anisotropic dispersing channel by appending the partial Differential Eq. (PDE) after generating the dissipated picture. An additional way to achieve smoothing is by means of a dispersion tool, absent from the boundaries and corners.

Anisotropic separation is a traditional smoothing approach in which the smoothing system is dependent upon the subsequent PDE regulating mechanism, as shown in Eq. (1):

3.2.3.

where Im represents the weighting direction's picture intensity. div is a divergence operator, ∇ is a gradient operator, and t is the time. The directionality of smoothing is provided by a structure tensor called T. It is built using a Gaussian kernel Kρ to convolve the sum of outer products of ∇Im over all weighted directions, yielding a common gradient tensor G, as expressed in Eq. (2):

3.2.3.

where the outer product operator is denoted by ⊗. The gradient tensor's spatial size is determined by the Gaussian kernel's standard deviation, or parameter ρ.

3.3. Image Segmentation

Segmentation may be a fundamental problem in image depiction and classification. It depends on the significance of regularity, which relies upon the precise assignment and its unique situation. At this moment, in various clinical audits, segmentation remains done manually or is immovably overseen by human specialists. The extent of administrator supervision influences the execution of the segmentation technique as far as time utilization is concerned. Manual segmentation makes the division irreducible and crumbling. Subsequently, there's a real requirement for computerized CT segmentation apparatuses [21].

We created a process to produce ground-truthed masks from pancreas CT images for a straightforward binary segmentation job, where each pixel is classified as background or plant. To create high-resolution and high-quality image masks, this protocol combines a thresholding method of automatic picture segmentation with manual postprocessing and mask modification. To enable the extraction of the tumour region for use in later stages, the perfect picture mask would have one pixel value for the pancreatic tissue and another pixel value for the remaining portion of the sheet. While the previously outlined segmentation method effectively grouped all pancreatic materials, each mask also contained nodule elements like label information and colour scheme. We instead designed a manual approach for the removal of these items because their automatic removal is very difficult [22].

3.3.1. Segmentation Model Performance

By contrasting the ground-truth labels we created for the 80 validation photos with the predicted pixel labels from the U-Net, we were able to assess the effectiveness of our model. Our model produced projected masks with a 0.95 Sørensen–Dice coefficient for each of the 80 images in the validation set.

The U-Net was fed the preprocessed pancreatic picture as its input. The encoding component was used to extract the hierarchical properties of the input CT scan image. The ROI was gradually created by the decoding portion using the encoder's computed properties. a series of steps utilised in the decoding and encoding processes. In the encoding section, the filter numbers were 64, 64, 128, 128, 256, 256, 512, 512, 512, 512, 512, 512, 512, 512, 512, 512, 512, 512, 512, 512, 512, 512, 512, 512, 512, 512, 512, 512, 512, 512, 512, 512, 512, 512, 512, 512, 512, 512, 512, 512, 512, 512, 512, 512, 512, 512, 512, 512, 512, 512, 512, 512, Three-size filters with a stride of one were employed. The final layer of the decoder, a convolutional layer with a single 1x filter, was used to extract the ROI [23].

The input images are 512*512*1 pixels in size. The blue box represents a multi-channel attribute layout, and a value across the upper left of the box will be its channel number. The white box represents batch normalization. A leaky ReLU is indicated by a grey box. A green box depicts a dropout module. This is a contracting channel and an expanding route in the U-net CNN setup. The contracting route has a convolutional network-like architecture. This is characterised by a 2x2 max pooling function with a factor of 2 for down-sampling, and two 3x3 convolutions (unpadded convolutions) applied repeatedly, all preceded by a rectified linear unit (ReLU). They raised the number of attribute channels for each down-sampled phase. In contrast to a contractual channel, an expanding route was composed of two 3x3 convolutions, a ReLU, a concatenation primarily with the cropped feature map of the contracting path, an up-sampling of a feature map, and a 2x2 convolution (also known as an “up-convolution”) that lowered numerous feature channels.

Cropping has been required in NPC 5 because of a decrease in boundary pixels within every convolution of the Provisional ROI, relying on the CT scan image. In the last layer, a 1x1 convolution has been utilized to transform every 64-component feature vector towards an appropriate number of classes. Within the last layer, a convolution is employed for mapping a feature towards the intended value, which would have been the intensity of a CT scan image. As a result, a huge number of picture characteristics were employed in the expansion route to rebuild a newer picture of a similar size to that of the input one. Figure 4 depicts the U-net installation. In our network, or something that differed from traditional U-net, we implemented batch normalization and leaky ReLU. Our U-net has been built using the Keras framework, which is a high-level neural network [24] API utilizing Tensorflow as a backend. In approximately, the U-net network under this analysis has 23 convolutional layers. Here, we also chose the source tile size since most 2x2 max-pooling processes were performed about a layer by an even x- as well as y151 dimension, allowing smooth tiling of an output segmentation map.

Fig. (4).

Fig. (4)

The architecture of U-net.

The L2 loss function applied in this network is defined in Eq. (3):

3.3.1.

Where I stands for the pancreas image, C for the matching ROI.

As a feature extractor, this perceptual loss was calculated using a VGG16 network, given by Eq. (4):

The definition for Lunet ploss is,

3.3.1.

Where I represent the pancreatic image, ||.|| is the L2 standard, and VGG is the 9th convolutional VGG 16-layer output. Fig. (4) illustrates the U-net architecture.

3.3.2. Model Training

Utilize the features that have been retrieved and their associated labels to train an RL model that is deep. To minimize the loss function and optimize the model's parameters, use an optimizer like Adam or SGD with momentum. To find the best possible model parameter values that minimize the loss function, one can utilize the SGD algorithm.

It is not possible to precisely partition the pancreatic tumor area in CT scans using the FCN and DenseNet method. In comparison to existing segmentation algorithms, the results demonstrate that the proposed method provides superior performance [25]. Despite preserving important details like edges and textures, the suggested method outperforms, according to the results. The original image is shown by (a) in Fig. (5), the FCM image by (b), the Densenet image by (c), and the proposed approach by (d) in the fourth image. These numbers show that, compared to alternative cluster-based methods, the suggested method produces higher-quality visuals for the aforementioned segmented images.

Fig. (5).

Fig. (5)

Performance value of segmentation.

3.4. Ensemble Model Definition

Classification is the data mining function that places the elements in the dataset into target groups or classes. Predicting the target class with perfect accuracy for every record in the datasets is the primary objective of the classification process. Here, we employ the three primary categorisation methods, FCN, U-Net, and DenseNet. Here, two classes, the benign class and the malignant class, are used to build the classification model. The high precision value of “1” produced by the Ensemble Meta classifier means that the benign class cannot be classified as malignant. It has a recall score of “0.78,” which suggests that the malignant class is not included in the benign class classification. When DenseNet, U-Net, and FCN are merged serially, the result is higher accuracy for PC detection. The following classifiers are used to classify the benign class and malignant class from the TCIA dataset based on the selected features.

3.4.1. DenseNet

Different CNNs provide special features of applications that fit the needs and surroundings of the medical field. Because DenseNet has a distinct technological and medical edge over its CNN rivals, ResNet in particular, these CNN models are widely used nowadays. The best classification results were obtained by DenseNet convolutional networks. DenseNet has 121 layers and an architecture that connects all of them, allowing each layer to learn important features from the layers that came before it, ultimately increasing the effectiveness of network training [26]. Since DenseNet uses fewer parameters than ResNet and due to the DenseNet model effectively addresses overfitting issues, network training in DenseNet is less complicated than in ResNet. DenseNet's dense block, which greatly facilitates data transfer between layers, is one of its most distinctive features. Three by three convolution layers, BN, and ReLU make up the DenseNet block. DenseNet blocks are expressed using Eq. (5).

3.4.1.

DenseNet layers are denoted by (0, 1, ..., l-1) in the formulas above, and the density of the feature map obtained from DenseNet layers121 is represented by [L0, L1, … … Li-1].

Due to its concatenation technique rather than feature addition, as ResNet did, DenseNet differed greatly from ResNet. DenseNet's feature reduces the process's computational load considerably. The author goes on to say that the DenseNet CNN model's special abilities enable feature propagation, mitigate diminishing gradient problems, and encourage feature reuse.

The layer distribution in groups of DenseNet networks is represented by Eq. (6). DenseNet blocks are divided into dense segments that are composed of uniformly sized feature mappings that are consistent across the network. The layers that reside in between are referred to as Transition Layers, and they handle down-sampling by using batch normalization techniques like 2x2 pooling layers and 1x1 CovLayer.

3.4.1.

The researchers' experimental investigation also showed that DenseNet performed and was more accurate as the number of parameters increased, without experiencing any problems with performance, efficiency, or overfitting. According to a study, DenseNet used many complex data sets and achieved highly encouraging projected outcomes under various scenarios. This proved that, in contrast to its competitors, DenseNet did not need more parameters or more intricate calculations to perform at its best. The networks' accuracy and performance would be further enhanced with the addition of hyperparameters.

3.4.2. Fully Convolutional Network

A key component of classifying hyperspectral images is classifier design. Thanks to developments in machine learning, CNN is an effective classifier that can handle difficult nonlinear difficulties and has excellent self-learning and self-adaptive capabilities. CNN has become a major player in the image classification space [27]. This section describes how to use an AdaBound optimiser and a convolutional neural network based on the enhanced elephant herding method to recognise hyperspectral images. Convolution neural network: each node chooses the characteristic that sets it apart and simultaneously extracts all of the important feature parameters, so the precision of the picture processing is not limited by the order in which it is used. The CNN framework for hyperspectral image classification utilizes feature calculation based on Eq. (7):

3.4.2.

Where Inline graphic denotes the quantity of input characteristics. Inline graphic represents the output features, while k is a constant that allows CNN's hidden layer nodes to have an integer range from:

3.4.2.

Training time is also impacted by the CNN's initial thresholds and weights, which are assigned to values between -1 and 1. Low robustness affects CNN's outputs and convergence outcomes. Thus, choosing the best starting weights and thresholds will greatly improve CNN performance. The prediction error is minimized using the loss function shown in Eq. (8):

3.4.2.

Where ϑ is the predicted output, ρi is the needed expected feature output, and Ŷi is the feature vector that has combined the CNN threshold values and initial weights.

3.4.3. U-Net

The proposed methodology utilizes a specialized semantic segmentation network founded on convolutional neural networks (CNN). Semantic segmentation, or pixel-to-pixel classification, links each pixel in an image to a class label present in the corresponding ground truth image. In this task, foreground pixels, denoted by 0 (bright pixel), represent glands, while background pixels, indicated by 1 (black pixel), represent the background class labels. The U-net has a technique that guarantees accurate local information, which down sampling in other segmentation systems, is lost due to downsampling. A symmetric expanding path is located on the right side of the Unet architecture, whereas a contracting path is located on the left. Using the traditional convolutional network layout, the contracting path functions as an encoder to capture the context. The two unpadded 3x3 convolutions that make up the contracting path/encoder are each followed by a ReLU activation function. The resulting convolutional output is then further down-sampled using a 2x2 max-pooling operator with a stride of 2. With each downsampling, the feature channels are twice [28]. In the encoding stage of the suggested custom-tailored architecture, 16, 32, 64, 128, 256, and 512 filters are used initially. The number of filters in all encoder levels has been significantly decreased in comparison to the traditional U-net architecture to minimize undesired noise and minimise the possibility of over-segmentation, which is frequently brought on by an excessive number of filters. The symmetric expanding path is utilized to give precise localization. Transposed convolutions, sometimes referred to as backward-stride convolutions, make up the expanding route and up-sample the feature maps while halving their quantity. The corresponding feature maps from the encoder path that were obtained via skip connections are mixed with the acquired up-sampled feature maps. ReLU activation is performed after two 3x3 convolution procedures on the resultant feature maps. As a result, the network can be trained to produce output that is more accurate using concatenated data. To obtain the necessary segmentation probability map, a 1x1 convolution is employed as the final step of the decoder phase. As a result, an end-to-end FCN with skip connections is what was obtained [29].

3.5. Model Evaluation

Evaluate the performance of the trained model using a test dataset and metrics using libraries such as sklearn. These metrics can be used to evaluate the model's performance and compare it to other models. Table 1 shows the performance metrics.

Table 1.

Performance metrics.

Preprocessing
PSNR graphic file with name CMIM-22-E15734056420925-tf1.jpg (9)
MSE graphic file with name CMIM-22-E15734056420925-tf2.jpg (10)
SSMI graphic file with name CMIM-22-E15734056420925-tf3.jpg (11)
Segmentation
Jaccard Index graphic file with name CMIM-22-E15734056420925-tf4.jpg (12)
Dice Overlap Index (DOI) graphic file with name CMIM-22-E15734056420925-tf5.jpg (13)
Similarity Index SI graphic file with name CMIM-22-E15734056420925-tf6.jpg (14)
Absolute Volume Measurement Error (AVME) graphic file with name CMIM-22-E15734056420925-tf7.jpg (15)
Figure of Merit (ε) graphic file with name CMIM-22-E15734056420925-tf8.jpg (16)
Classification
Precision graphic file with name CMIM-22-E15734056420925-tf9.jpg (17)
Recall graphic file with name CMIM-22-E15734056420925-tf10.jpg (18)
F1 score graphic file with name CMIM-22-E15734056420925-tf11.jpg (19)

Deploy the trained model in a real-world setting and test its performance on unseen images using TensorFlow or PyTorch. This can be done by using the trained model to make predictions on new images and comparing the predictions [30].

4. RESULTS AND DISCUSSION

In this section analysis of the segmentation process, which has been done by the sparse subspace clustering method, Feature Extraction, which has been done by the PCA method, CNN with Modified Sparrow search algorithm, and the classification process are discussed.

Table 2 shows the effectiveness of several augmentation techniques using various measures of the parameters. In this examination, the performance of the total augmentation technique was superior to that of the individual techniques.

Table 2.

Comparison analysis of different data augmentation techniques with classification.

Data Augmentation Methods Precision (%) Recall (%) F-measure (%) MSE (%)
Flipping 97.46 95.32 97.21 6.48
Cropping 96.40 95.59 96.44 5.67
Rotation 94.52 95.09 96.21 6.97
Noise injection 93.58 94.68 95.22 6.49
BADF 98.49 97.92 98.64 4.63

Figure 6 illustrates the accuracy performance of different augmentation strategies: the flipping technique reached 96.46%, the cropping technique attained 95.21%, and the rotation method achieved 97.36%. The model exhibiting the lowest accuracy, 94.565%, was obtained using the noise injection strategy. The Combination of WT surpassed the individual approaches in accuracy, achieving a classification accuracy of 98.91%. This section evaluates the comparative studies of the proposed models.

Fig. (6).

Fig. (6)

Comparison of classification accuracy with augmentation.

For preprocessed pancreas cancer, performance measurements such as PSNR, MSE, and SSIM are analyzed, and values obtained are displayed in Table 3. The PSNR is significantly high in all image samples when examining Table 3, relative to MSE values for sample images. Normally, the SSIM values lie between -1 to 1; here, the values of SSIM are approximately equal to 1this denotes our proposed preprocessing outperforms well.

Table 3.

Performance evaluation for various filters in different grades of images.

Metrics PSNR MSE SSIM
Images ADF BADF ADF BADF ADF BADF
Images 1 31.5247 39.4470 3.369335 0.022112 0.7435 0.8293
Images 2 31.7810 40.6386 3.176197 0.016806 0.6864 0.7163
Images 3 34.3646 39.3762 1.752057 0.022475 0.7157 0.9921
Images 4 30.0447 39.1034 4.737437 0.023933 0.6403 0.8206

From Table 4, it can be seen that greater True Positive values and lower False Negative values are always preferable for better results. The results of the experiment indicate that alternative clustering models that employ the optimized approach have a strong relationship with the overall accuracy. Our tests on several photographs show that the suggested technique is effective in both situations when the items in the image are fuzzy and clear from the surrounding background. For the suggested paradigm, each MCC grade is high. The MCC typically ranges from -1 to 1, with -1 denoting an improper classification and 1 denoting the correct classification.In the case of precision, processing time, and efficiency, the efficiency of the suggested image segmentation method was evaluated by comparing it with some advanced segmentation algorithms. Accuracy was measured for each image processed by comparing outcomes with the simple facts. The empirical results show that our proposed solution is successful in solving a greater number of segmentation problems by enhancing the consistency and accuracy of segmentation with less implementation time. The proposed work's Dice Coefficient value (0.974) is shown to be much higher than that of existing approaches.

Table 4.

Performance evaluation of proposed segmentation models.

Images 1 METRICS FCN Dense Net U-Net
DOI 0.764 0.815 0.926
J(X,Y) 0.617 0.771 0.837
MCC 0.817 0.875 0.940
SI 0.957 0.992 0.975
Images 2 DOI 0.988 0.961 0.984
J(X,Y) 0.828 0.926 0.970
MCC 0.914 0.917 0.982
SI 0.974 0.986 0.988
Images 3 DOI 0.918 0.963 0.968
J(X,Y) 0.942 0.929 0.940
MCC 0914 0.959 0.964
SI 0.991 0.992 0.993
Images 4 DOI 0.846 0.933 0.942
J(X,Y) 0.656 0.805 0.843
MCC 0.747 0.963 0.943
SI 0.95 0.96 0.996
DOI 0.846 0.933 0.942

Figure 7 presents information regarding the segmentation period for the testing data. A comparison is made between the computational effectiveness of four existing approaches and the proposed method. Computation time, also referred to as “running time,” denotes the duration required to complete a computing operation.

Fig. (7).

Fig. (7)

Comparative analysis of segmentation time of different methods.

The suggested U-Net accuracy scheme is presented in Table 5. It U-Net classifiers benefit from improved resolution, sensitivity, accuracy, and specificity; the error value is lower than that of the recommended model, and the outcomes demonstrate the superior efficiency of the suggested technique. It has been demonstrated that using the suggested strategy for early tumour identification improves the standard and precision of clinical practice. The suggested strategy for tumour monitoring has been put into practice to assist pathologists in determining the precise tumour area and type. The segmentation accuracy attained using several techniques is displayed in Fig. (8).

Table 5.

Performance with state-of-the-art models.

Methods Accuracy (%)
Grab cut [31] 88
K-means clustering [32] 92
Fuzzy c means clustering [33] 93
Proposed Techniques -
FCN 94.7
Dense Net 95
U-Net 97.3

Fig. (8).

Fig. (8)

Comparative accuracy analysis of different methods, including Grabcut, clustering-based approaches, and deep learning models.

It has been demonstrated that applying the suggested technique for early identification of a minute tumor improves clinical practice quality and accuracy, lowering the possibility of incorrect diagnosis and poor care. It makes it easier for doctors to detect pancreatic cancers for subsequent treatment. The proposed system can help doctors know the type of pancreatic tumor, the type of bleeding, and for further treatment. There is no human intervention.

Figure 9a illustrates the training and validation loss of the proposed ensemble classifier, while Fig. (9b) shows the training and validation accuracy across 30 epochs. The losses are presented on a linear scale in the upper plot and on a logarithmic scale in the lower plot. The x-axis in both graphs displays epoch numbers ranging from 0 to 30. The y-axis represents loss, with training loss indicated by the blue line and validation loss indicated by the orange line.

Fig. (9).

Fig. (9)

(a) Training and Validation loss of proposed Ensemble classifier; (b) Training and Validation accuracy of proposed Ensemble classifier.

The training and validation losses exhibit a significant decline during the initial epochs, suggesting that the model rapidly learns from the training data. The training loss progressively decreases over time, indicating an improvement in the model's performance on the training set. The validation loss exhibits greater fluctuations than the training loss, despite an overall decrease. These oscillations are normal when the model tries to apply what it has learnt to fresh, unobserved input.

An efficient diagnostic system was developed utilizing an ensemble classifier for the classification of pancreatic tumors based on pancreatic images. The deep learning method is formulated to address challenges related to the intensity in the soft region of the pancreas by utilizing optimal features. This method has demonstrated a superior accuracy rate across various image types. Table 6 presents a comparison of the performance metrics for the proposed ensemble methods.

Table 6.

Comparison of various performance metrics of proposed ensemble methods.

Methods Learning rate Accuracy Loss Precision (%) Recall (%) F-measure (%) AUC
DenseNet 0.01 96.40 3.6 97.46 95.32 97.21 90.48
FCN 0.01 94.52 5.48 96.40 95.59 96.44 90.67
U-Net 0.01 93.58 6.42 94.52 95.09 96.21 90.97
Ensemble model 0.01 98.7 1.3 98.7 97.92 98.64 99.63

A deep learning approach for evaluating the levels of risk of pancreatic cancer patients is designed upon the modified ensemble classifier by developing models from healthcare data. An overall accuracy of 98.7% is attained in comparison to alternative techniques. Fig. (10) illustrates the performance values of the proposed methods. Multiple benchmark datasets were utilized to assess the integrated computer-aided diagnosis system, demonstrating that the aforementioned algorithms can effectively extract valuable patterns from healthcare data.

Fig. (10).

Fig. (10)

Comparative performance analysis of individual deep learning models and the proposed ensemble model.

To meet the primary objective of enhancing early and accurate detection of pancreatic tumors, especially small and non-nodular lesions, a comprehensive performance comparison was conducted against several state-of-the-art segmentation models. Evaluation was based on classification metrics including accuracy, error rate, recall, precision, F1-score, and AUC, as summarized in Table 7.

Table 7.

Quantitative comparison of accuracy, error rate, and other metrics across state-of-the-art models.

Method/Model Accuracy (%) Error Rate (%) Recall (%) AUC (%) Precision (%) F1 Score (%)
SegNet [34] 91.2 8.8 89.5 93 90.2 89.8
PSPNet (Pyramid Scene Parsing) [35] 94 6 92.4 94.5 92.3 91.7
DeepLabv3+ [36] 95.2 4.8 93.8 96.1 94.1 93.7
Attention U-Net [37] 96 4 94.9 95.7 93 92.6
BiSeNet (Real-time) [38] 92.8 7.2 90.7 95.4 92.9 92.2
TransUNet (Hybrid) [39] 97.1 2.9 96 96.8 94.7 94.5
Proposed Ensemble Model 98.7 1.3 97.92 99.63 98.7 98.64

Classical models such as SegNet and BiSeNet achieved lower accuracies of 91.20% and 92.80%, with higher error rates of 8.80% and 7.20%, respectively, reflecting limitations in capturing complex anatomical features of the pancreas. PSPNet, which leverages pyramid scene parsing for multiscale feature extraction, improved the accuracy to 94.00%, though a moderate error rate of 6.00% persisted.

More advanced models like DeepLabv3+ and Attention U-Net delivered higher segmentation performance with 95.30% and 96.10% accuracy, respectively. The hybrid TransUNet, incorporating transformer-based global attention mechanisms, further improved results with an accuracy of 97.10% and an error rate of 2.90%.

Notably, as illustrated in Fig. (11), the proposed ensemble model, which integrates DenseNet, FCN, and U-Net outputs followed by PCA-based dimensionality reduction, achieved the highest classification accuracy of 98.70% and the lowest error rate of 1.30%. Fig. (11) visually supports the superiority of the proposed model by demonstrating enhanced tumor boundary delineation and effective localization of early-stage lesions, which are often missed by conventional architectures.

Fig. (11).

Fig. (11)

Comparative performance of state-of-the-art models based on accuracy, error rate, recall, auc, precision, and f1 score.

In addition to accuracy and error rate, the evaluation also incorporated key diagnostic metrics such as Recall, Precision, AUC, and F1 Score parameters, which are critical for assessing the clinical reliability and robustness of segmentation models. The proposed ensemble model achieved the highest recall (97.92%), precision (98.7%), and F1 score (98.64%) among all the compared methods, demonstrating its exceptional ability to minimize false negatives and maximize the correct identification of tumor regions. Moreover, it attained the highest AUC value of 99.63%, indicating superior discriminative capability and robustness across varying threshold settings. These additional performance metrics reinforce the model’s strength in addressing the challenges of detecting small lesions and support its clinical reliability and sensitivity. The model’s consistent superiority across all evaluation criteria underscores its potential as a significant advancement in the domain of pancreatic cancer segmentation and its readiness for clinical translation.

In summary, the proposed ensemble model consistently outperformed all compared state-of-the-art segmentation methods across multiple evaluation metrics. These findings confirm the model’s readiness for clinical use and its effectiveness in supporting early pancreatic cancer diagnosis, the primary goal of this study. This significant performance gain not only validates the robustness and generalization capability of the proposed methodology but also strongly supports its potential for real-world clinical application in early-stage pancreatic cancer detection. Therefore, the findings align with and effectively fulfill the core objective of this research.

5. LIMITATIONS AND FUTURE WORK

While the proposed framework demonstrates promising results, several limitations need to be acknowledged. Firstly, the study relies on public datasets, which, although widely accepted for benchmarking, may not fully reflect real-world variability in patient populations and imaging protocols. Additionally, the model's performance may be influenced by biases in the training data, such as differences in tumor characteristics or patient demographics. However, the use of ensemble classification and dimensionality reduction techniques helps mitigate such biases and enhances the model's robustness.

Furthermore, the study focuses on CT imaging data, which, while being the standard modality for pancreatic evaluation, may not be universally available or suitable for all patient populations. Future studies should aim to validate the model's performance on diverse datasets and explore the integration of other imaging modalities or clinical data to further improve diagnostic accuracy. Moreover, the interpretability and explainability of the model's decisions remain areas for future enhancement, especially to ensure transparency and trustworthiness in clinical applications. Despite partial interpretability achieved through U-Net-based segmentation and PCA feature visualization, more clinician-friendly explainability tools can be explored. Addressing these limitations will be crucial to translating the proposed framework into clinical practice and realizing its potential to improve patient outcomes.

CONCLUSION

Pancreatic cancer remains one of the leading causes of mortality worldwide, particularly among diabetic individuals over the age of 50. Early symptoms such as jaundice, combined with the presence of other tumors, often complicate timely diagnosis. Additionally, the coexistence of related conditions, including pancreatitis, cystic fibrosis, and diabetes, renders traditional diagnostic approaches less accurate and effective. To address these challenges, this study presents a novel deep learning based pancreatic disease diagnosis system incorporating an augmentation model. The findings suggest that optimized deep learning techniques can effectively classify and diagnose diseases using CT imaging data. The proposed method utilizes U-Net for extracting regions of interest (ROIs) from CT scans, while multiple testing conditions reveal its superior performance over conventional classification methods. The model was evaluated using standard datasets to classify CT scan images as normal or abnormal, demonstrating improved accuracy and efficiency. Noise removal was performed using a Boosted Adaptive Diffusion Filter (BADF), followed by tumor segmentation via a U-Net model. Hyperparameters were tuned using the Adam optimizer, and classification was carried out using an ensemble approach. The ensemble model integrates outputs from DenseNet, FCN, and U-Net architectures, followed by PCA-based dimensionality reduction to enhance classification performance. Evaluation metrics and real-world deployment confirm the model’s high accuracy in detecting small pancreatic tumors. Specifically, for tumors smaller than 2 cm, the proposed system achieved an AUC of 99.63%, accuracy of 98.7%, precision of 98.7%, recall of 97.92%, and F1-score of 98.64%, reflecting strong clinical reliability and robustness. These results also validate the model’s effectiveness in identifying small and early-stage lesions often overlooked by conventional architectures. This study demonstrates that artificial intelligence, when integrated with advanced imaging and deep learning techniques, holds significant potential for improving medical image analysis, enhancing disease understanding, and enabling earlier diagnosis of pancreatic cancer.

ACKNOWLEDGEMENTS

Declared none.

LIST OF ABBREVIATIONS

AI

Artificial Intelligence

AUC

Area Under the Curve

BADF

Boosted Adaptive Diffusion Filter

CAD

Computer-Aided Diagnosis/Detection

CEA

Carcinoembryonic Antigen

CNN

Convolutional Neural Network

CT

Computed Tomography

DL

Deep Learning

FCN

Fully Convolutional Network

ML

Machine Learning

MRI

Magnetic Resonance Imaging

PCA

Principal Component Analysis

PC

Pancreatic Cancer

PDAC

Pancreatic Adenocarcinoma

PDE

Partial Differential Equation

PET

Positron Emission Tomography

ROI

Region of Interest

TCIA

The Cancer Imaging Archive

AUTHORS' CONTRIBUTIONS

The authors confirm their contribution to the paper as follows: P.S.: Analysis and interpretation of results; R.K.: Validation: M.V.M., M.S.: Draft manuscript. All authors reviewed the results and approved the final version of the manuscript.

ETHICS APPROVAL AND CONSENT TO PARTICIPATE

Not applicable.

HUMAN AND ANIMAL RIGHTS

Not Applicable.

CONSENT FOR PUBLICATION

Not applicable.

AVAILABILITY OF DATA AND MATERIALS

All data generated or analyzed during this study are included in this published article.

FUNDING

None.

CONFLICT OF INTEREST

The authors declare no conflict of interest, financial or otherwise.

REFERENCES

  • 1.Siegel R.L., Giaquinto A.N., Jemal A. Cancer statistics, 2024. CA Cancer J. Clin. 2024;74(1):12–49. doi: 10.3322/caac.21820. [DOI] [PubMed] [Google Scholar]
  • 2.Yokoyama S., Hamada T., Higashi M., Matsuo K., Maemura K., Kurahara H., Horinouchi M., Hiraki T., Sugimoto T., Akahane T., Yonezawa S., Kornmann M., Batra S.K., Hollingsworth M.A., Tanimoto A. Predicted prognosis of patients with pancreatic cancer by machine learning. Clin. Cancer Res. 2020;26(10):2411–2421. doi: 10.1158/1078-0432.CCR-19-1247. [DOI] [PubMed] [Google Scholar]
  • 3.Janssen B.V., Verhoef S., Wesdorp N.J., Huiskens J., de Boer O.J., Marquering H., Stoker J., Kazemier G., Besselink M.G. Imaging-based machine-learning models to predict clinical outcomes and identify biomarkers in pancreatic cancer: A scoping review. Ann. Surg. 2022;275(3):560–567. doi: 10.1097/SLA.0000000000005349. [DOI] [PubMed] [Google Scholar]
  • 4.Singhi A.D., Koay E.J., Chari S.T., Maitra A. Early detection of pancreatic cancer: Opportunities and challenges. Gastroenterology. 2019;156(7):2024–2040. doi: 10.1053/j.gastro.2019.01.259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Yokoyama S., Kitamoto S., Higashi M., Goto Y., Hara T., Ikebe D., Yamaguchi T., Arisaka Y., Niihara T., Nishimata H., Tanaka S., Takaori K., Batra S.K., Yonezawa S. Diagnosis of pancreatic neoplasms using a novel method of DNA methylation analysis of mucin expression in pancreatic juice. PLoS One. 2014;9(4):e93760. doi: 10.1371/journal.pone.0093760. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Janssen B.V., Theijse R., van Roessel S., de Ruiter R., Berkel A., Huiskens J., Busch O.R., Wilmink J.W., Kazemier G., Valkema P., Farina A., Verheij J., de Boer O.J., Besselink M.G. Artificial intelligence-based segmentation of residual tumor in histopathology of pancreatic cancer after neoadjuvant treatment. Cancers. 2021;13(20):5089. doi: 10.3390/cancers13205089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.McGuigan A., Kelly P., Turkington R.C., Jones C., Coleman H.G., McCain R.S. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes. World J. Gastroenterol. 2018;24(43):4846–4861. doi: 10.3748/wjg.v24.i43.4846. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Zhang Q., Zeng L., Chen Y., Lian G., Qian C., Chen S., Li J., Huang K. Pancreatic cancer epidemiology, detection, and management. Gastroenterol. Res. Pract. 2016;2016(1):1–10. doi: 10.1155/2016/8962321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Ilic M., Ilic I. Epidemiology of pancreatic cancer. World J. Gastroenterol. 2016;22(44):9694–9705. doi: 10.3748/wjg.v22.i44.9694. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Vasen H., Ibrahim I., Ponce C.G., Slater E.P., Matthäi E., Carrato A., Earl J., Robbers K., van Mil A.M., Potjer T., Bonsing B.A., de Vos tot Nederveen Cappel W.H., Bergman W., Wasser M., Morreau H., Klöppel G., Schicker C., Steinkamp M., Figiel J., Esposito I., Mocci E., Vazquez-Sequeiros E., Sanjuanbenito A., Muñoz-Beltran M., Montans J., Langer P., Fendrich V., Bartsch D.K. Benefit of surveillance for pancreatic cancer in high-risk individuals: outcome of long-term prospective follow-up studies from three European expert centers. J. Clin. Oncol. 2016;34(17):2010–2019. doi: 10.1200/JCO.2015.64.0730. [DOI] [PubMed] [Google Scholar]
  • 11.Hu J.X., Zhao C.F., Chen W.B., Liu Q.C., Li Q.W., Lin Y.Y., Gao F. Pancreatic cancer: A review of epidemiology, trend, and risk factors. World J. Gastroenterol. 2021;27(27):4298–4321. doi: 10.3748/wjg.v27.i27.4298. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Neoptolemos J.P., Kleeff J., Michl P., Costello E., Greenhalf W., Palmer D.H. Therapeutic developments in pancreatic cancer: current and future perspectives. Nat. Rev. Gastroenterol. Hepatol. 2018;15(6):333–348. doi: 10.1038/s41575-018-0005-x. [DOI] [PubMed] [Google Scholar]
  • 13.Zhang L., Sanagapalli S., Stoita A. Challenges in diagnosis of pancreatic cancer. World J. Gastroenterol. 2018;24(19):2047–2060. doi: 10.3748/wjg.v24.i19.2047. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Gilliland T., Villafane-Ferriol N., Shah K., Shah R., Tran Cao H., Massarweh N., Silberfein E., Choi E., Hsu C., McElhany A., Barakat O., Fisher W., Van Buren G., II Nutritional and metabolic derangements in pancreatic cancer and pancreatic resection. Nutrients. 2017;9(3):243. doi: 10.3390/nu9030243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Singhi A.D., George B., Greenbowe J.R., Chung J., Suh J., Maitra A., Klempner S.J., Hendifar A., Milind J.M., Golan T., Brand R.E., Zureikat A.H., Roy S., Schrock A.B., Miller V.A., Ross J.S., Ali S.M., Bahary N. Real-time targeted genome profile analysis of pancreatic ductal adenocarcinomas identifies genetic alterations that might be targeted with existing drugs or used as biomarkers. Gastroenterology. 2019;156(8):2242–2253.e4. doi: 10.1053/j.gastro.2019.02.037. [DOI] [PubMed] [Google Scholar]
  • 16.Zhao Z, Liu W. Pancreatic cancer: A review of risk factors, diagnosis, and treatment. Technol Cancer Res Treat. 2020;19:1533033820962117. doi: 10.1177/1533033820962117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Versteijne E., van Dam J.L., Suker M., Janssen Q.P., Groothuis K., Akkermans-Vogelaar J.M., Besselink M.G., Bonsing B.A., Buijsen J., Busch O.R., Creemers G.J.M., van Dam R.M., Eskens F.A.L.M., Festen S., de Groot J.W.B., Groot Koerkamp B., de Hingh I.H., Homs M.Y.V., van Hooft J.E., Kerver E.D., Luelmo S.A.C., Neelis K.J., Nuyttens J., Paardekooper G.M.R.M., Patijn G.A., van der Sangen M.J.C., de Vos-Geelen J., Wilmink J.W., Zwinderman A.H., Punt C.J., van Tienhoven G., van Eijck C.H.J. Dutch Pancreatic Cancer Group. Neoadjuvant chemoradiotherapy versus upfront surgery for resectable and borderline resectable pancreatic cancer: Long-term results of the Dutch randomized PREOPANC trial. J. Clin. Oncol. 2022;40(11):1220–1230. doi: 10.1200/JCO.21.02233. [DOI] [PubMed] [Google Scholar]
  • 18.Karar M.E., El-Fishawy N., Radad M. Automated classification of urine biomarkers to diagnose pancreatic cancer using 1-D convolutional neural networks. J. Biol. Eng. 2023;17(1):28. doi: 10.1186/s13036-023-00340-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Nopour R. Establishment of prediction model for mortality risk of pancreatic cancer: A retrospective study. BMC Med. Inform. Decis. Mak. 2024;24(1):181. doi: 10.1186/s12911-024-02590-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Chen S.M., Phuc P.T., Nguyen P.A., Burton W., Lin S.J., Lin W.C., Lu C.Y., Hsu M.H., Cheng C.T., Hsu J.C. A novel prediction model of the risk of pancreatic cancer among diabetes patients using multiple clinical data and machine learning. Cancer Med. 2023;12(19):19987–19999. doi: 10.1002/cam4.6547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Vaiyapuri T, Dutta AK, Punithavathi ISH, Duraipandy P, Alotaibi SS, Alsolai H, Mohamed A, Mahgoub H. Intelligent deep-learning-enabled decision-making medical system for pancreatic tumor classification on CT Images. Healthcare. 2022;10(4):677. doi: 10.3390/healthcare10040677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Manesh V.M., Subramoniam M. Detection of human pancreatic cancer using ML and DL model: A state-of-the-art review.; 2023 Annual International Conference on Emerging Research Areas: International Conference on Intelligent Systems (AICERA/ICIS); Kanjirapally, Kerala, India, 2023 Nov 16-18, pp. 1-5. [DOI] [Google Scholar]
  • 23.Mikdadi D., O’Connell K.A., Meacham P.J., Dugan M.A., Ojiere M.O., Carlson T.B., Klenk J.A. Applications of artificial intelligence (AI) in ovarian cancer, pancreatic cancer, and image biomarker discovery. Cancer Biomark. 2022;33(2):173–184. doi: 10.3233/CBM-210301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Saftoiu A., Cazacu I.M., Udristoiu A., Gruionu L.G., Iacob A., Gruionu G. Artificial intelligence in pancreatic cancer: Toward precision diagnosis. Endosc. Ultrasound. 2019;8(6):357–359. doi: 10.4103/eus.eus_76_19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Kawai M., Fukuda A., Otomo R., Obata S., Minaga K., Asada M., Umemura A., Uenoyama Y., Hieda N., Morita T., Minami R., Marui S., Yamauchi Y., Nakai Y., Takada Y., Ikuta K., Yoshioka T., Mizukoshi K., Iwane K., Yamakawa G., Namikawa M., Sono M., Nagao M., Maruno T., Nakanishi Y., Hirai M., Kanda N., Shio S., Itani T., Fujii S., Kimura T., Matsumura K., Ohana M., Yazumi S., Kawanami C., Yamashita Y., Marusawa H., Watanabe T., Ito Y., Kudo M., Seno H. Early detection of pancreatic cancer by comprehensive serum miRNA sequencing with automated machine learning. Br. J. Cancer. 2024;131(7):1158–1168. doi: 10.1038/s41416-024-02794-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Chhikara J., Goel N., Rathee N. Deep learning techniques for pancreatic cancer analysis: A systematic review and implantation prerequisites. Procedia Comput. Sci. 2024;235:3118–3130. doi: 10.1016/j.procs.2024.04.295. [DOI] [Google Scholar]
  • 27.Daher H., Punchayil S.A., Ismail A.A.E., Fernandes R.R., Jacob J., Algazzar M.H., Mansour M. Advancements in pancreatic cancer detection: Integrating biomarkers, imaging technologies, and machine learning for early diagnosis. Cureus. 2024;16(3):e56583. doi: 10.7759/cureus.56583. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Javed S., Qureshi T.A., Gaddam S., Wang L., Azab L., Wachsman A.M., Chen W., Asadpour V., Jeon C.Y., Wu B., Xie Y., Pandol S.J., Li D. Risk prediction of pancreatic cancer using AI analysis of pancreatic subregions in computed tomography images. Front. Oncol. 2022;12:1007990. doi: 10.3389/fonc.2022.1007990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Mukherjee S., Patra A., Khasawneh H., Korfiatis P., Rajamohan N., Suman G., Majumder S., Panda A., Johnson M.P., Larson N.B., Wright D.E., Kline T.L., Fletcher J.G., Chari S.T., Goenka A.H. Radiomics-based machine-learning models can detect pancreatic cancer on prediagnostic computed tomography scans at a substantial lead time before clinical diagnosis. Gastroenterology. 2022;163(5):1435–1446.e3. doi: 10.1053/j.gastro.2022.06.066. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Pereira S.P., Oldfield L., Ney A., Hart P.A., Keane M.G., Pandol S.J., Li D., Greenhalf W., Jeon C.Y., Koay E.J., Almario C.V., Halloran C., Lennon A.M., Costello E. Early detection of pancreatic cancer. Lancet Gastroenterol. Hepatol. 2020;5(7):698–710. doi: 10.1016/S2468-1253(19)30416-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Versteijne E., Suker M., Groothuis K., Akkermans-Vogelaar J.M., Besselink M.G., Bonsing B.A., Buijsen J., Busch O.R., Creemers G.J.M., van Dam R.M., Eskens F.A.L.M., Festen S., de Groot J.W.B., Groot Koerkamp B., de Hingh I.H., Homs M.Y.V., van Hooft J.E., Kerver E.D., Luelmo S.A.C., Neelis K.J., Nuyttens J., Paardekooper G.M.R.M., Patijn G.A., van der Sangen M.J.C., de Vos-Geelen J., Wilmink J.W., Zwinderman A.H., Punt C.J., van Eijck C.H., van Tienhoven G. Dutch Pancreatic Cancer Group. Preoperative chemoradiotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer: Results of the Dutch randomized phase III PREOPANC trial. J. Clin. Oncol. 2020;38(16):1763–1773. doi: 10.1200/JCO.19.02274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Saad A.M., Turk T., Al-Husseini M.J., Abdel-Rahman O. Trends in pancreatic adenocarcinoma incidence and mortality in the United States in the last four decades; a SEER-based study. BMC Cancer. 2018;18(1):688. doi: 10.1186/s12885-018-4610-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Tempero MA. NCCN guidelines updates: Pancreatic cancer. J Natl Compr Canc Netw. 2019;17(5.5):603–605. doi: 10.6004/jnccn.2019.5007. [DOI] [PubMed] [Google Scholar]
  • 34.Badrinarayanan V., Kendall A., Cipolla R. Segnet: A deep convolutional encoder-decoder architecture for image segmentation. IEEE Trans. Pattern Anal. Mach. Intell. 2017;39(12):2481–2495. doi: 10.1109/TPAMI.2016.2644615. [DOI] [PubMed] [Google Scholar]
  • 35.Zhao H., Shi J., Qi X., Wang X., Jia J. Pyramid scene parsing network.; 2017 IEEE Conference on Computer Vision and Pattern Recognition (CVPR); Honolulu, HI, USA, 21-26 July 2017, pp. 6230-6239. [DOI] [Google Scholar]
  • 36.Chen L.C., Zhu Y., Papandreou G., Schroff F., Adam H. Encoder-decoder with atrous separable convolution for semantic image segmentation. In: Ferrari V., Hebert M., Sminchisescu C., Weiss Y., editors. Computer Vision – ECCV 2018. ECCV 2018. Vol. 11211. Cham: Springer; 2018. [DOI] [Google Scholar]
  • 37.Oktay O., Schlemper J., Folgoc L.L., Lee M., Heinrich M., Misawa K., Mori K., McDonagh S., Hammerla N.Y., Kainz B., Glocker B. Attention u-net: Learning where to look for the pancreas. arXiv. 2018:arXiv:1804.03999v3. doi: 10.48550/arXiv.1804.03999. [DOI] [Google Scholar]
  • 38.Yu C., Wang J., Peng C., Gao C., Yu G., Sang N. BiSeNet: Bilateral segmentation network for real-time semantic segmentation. In: Ferrari V., Hebert M., Sminchisescu C., Weiss Y., editors. Computer Vision – ECCV 2018. ECCV 2018. Vol. 11217. Cham: Springer; 2018. [DOI] [Google Scholar]
  • 39.Chen J., Lu Y., Yu Q., Luo X., Adeli E., Wang Y., Lu L., Yuille A.L., Zhou Y. Transunet: Transformers make strong encoders for medical image segmentation. arXiv. 2021:arXiv:2102.04306v1. doi: 10.48550/arXiv.2102.04306. [DOI] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

All data generated or analyzed during this study are included in this published article.


Articles from Current Medical Imaging are provided here courtesy of Bentham Science Publishers

RESOURCES